Response to comment on "Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics".
Jonas BovijnKristi KrebsChia-Yen ChenRuth BoxallJenny C CensinTeresa FerreiraSara L PulitCraig A GlastonburySamantha LaberIona Y MillwoodKuang LinLiming LiZhengming ChenLili A MilaniGeorge Davey SmithRobin G WaltersReedik MägiBenjamin M NealeCecilia M LindgrenMichael V HolmesPublished in: Science translational medicine (2021)
[Figure: see text].